Platform Technologies and Translational Research

Platform Technologies

This diagram outlines the translational research pipeline at UCL, focusing on our core infrastructure and technologies. The aim is to facilitate high quality science in our cross-cutting themes (biomarker discovery, therapeutic pipeline and experimental medicine, healthy lifespan and translational imaging) by providing a world-class environment. Integration of our capabilities in basic science, clinical research and in population studies provides input into this pipeline.

PT image

The platforms include, but are not limited to, genomics, proteomics, imaging, transgenics and animal services, biobanks and the informatics required to underpin these activities.

• Each platform must

– Support and facilitate research

– Provide a service and training

– Be efficient and fully cost-recovered

For further information, see Platform Technologies.

A critical element in translational research information integration, is enabling access to clinical data, which is often stored in incompatable information systems at different clinics and hospitals, and which are subject to stringent ethical and privacy constraints. Computational and Systems Medicine (CSM) is beginning to work with some of UCL's clinical Partners to address these issues, initially in the context of biobanks.

Translational Research Office

Translational research is the process of translating ideas and findings in the laboratory through to treatment or preventions in the clinic.  Biobanks and other Platform Technologies can have a key role in tranlsational research.

UCL Translational Research Office enhances the translational research culture across UCL.

For further information on the UCL Translational Research Office, please see TRO 

Page last modified on 18 sep 10 08:08 by Jacky A Pallas